Analyse @NimaSharifiMD's tweets
@NimaSharifiMD
| 4,095 followers
Key takeaways from @DrRanaMcKay’s #ASCO20 presentation on neoadjuvant hormonal tx: 1) prior studies suggest SPOP mutants are better responders 2) no difference in path CR when adding apalutamide to abi+ADT (~20% in both groups) https://t.co/yWM3VvkJIj